Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Tropoelastin interacts with cell-surface glycosaminoglycans via its COOH-terminal domain.

Broekelmann TJ, Kozel BA, Ishibashi H, Werneck CC, Keeley FW, Zhang L, Mecham RP.

J Biol Chem. 2005 Dec 9;280(49):40939-47. Epub 2005 Sep 27.

2.

The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.

Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM.

J Biol Chem. 1999 Feb 26;274(9):5810-22.

3.

Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.

Murphy-Ullrich JE, Gurusiddappa S, Frazier WA, Höök M.

J Biol Chem. 1993 Dec 15;268(35):26784-9.

4.
5.

A unique sequence of the laminin alpha 3 G domain binds to heparin and promotes cell adhesion through syndecan-2 and -4.

Utani A, Nomizu M, Matsuura H, Kato K, Kobayashi T, Takeda U, Aota S, Nielsen PK, Shinkai H.

J Biol Chem. 2001 Aug 3;276(31):28779-88. Epub 2001 May 23.

6.

Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.

Clezardin P, Lawler J, Amiral J, Quentin G, Delmas P.

Biochem J. 1997 Feb 1;321 ( Pt 3):819-27.

8.

Cell type-specific differences in glycosaminoglycans modulate the biological activity of a heparin-binding peptide (RKRLQVQLSIRT) from the G domain of the laminin alpha1 chain.

Hoffman MP, Engbring JA, Nielsen PK, Vargas J, Steinberg Z, Karmand AJ, Nomizu M, Yamada Y, Kleinman HK.

J Biol Chem. 2001 Jun 22;276(25):22077-85. Epub 2001 Apr 13.

9.

Cellular interactions with elastin.

Rodgers UR, Weiss AS.

Pathol Biol (Paris). 2005 Sep;53(7):390-8. Epub 2005 Jan 19. Review.

PMID:
16085115
10.

Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells.

Incardona F, Lawler J, Cataldo D, Panet A, Legrand Y, Foidart JM, Legrand C.

J Cell Biochem. 1996 Sep 15;62(4):431-42.

PMID:
8891889
11.

Different usage of the glycosaminoglycan attachment sites of biglycan.

Kresse H, Seidler DG, Muller M, Breuer E, Hausser H, Roughley PJ, Schonherr E.

J Biol Chem. 2001 Apr 20;276(16):13411-6. Epub 2001 Jan 5.

12.
13.

Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.

Mast AE, Higuchi DA, Huang ZF, Warshawsky I, Schwartz AL, Broze GJ Jr.

Biochem J. 1997 Oct 15;327 ( Pt 2):577-83.

14.

Molecular features of the collagen V heparin binding site.

Delacoux F, Fichard A, Geourjon C, Garrone R, Ruggiero F.

J Biol Chem. 1998 Jun 12;273(24):15069-76.

15.

Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.

Friedrich MV, Göhring W, Mörgelin M, Brancaccio A, David G, Timpl R.

J Mol Biol. 1999 Nov 19;294(1):259-70.

PMID:
10556044
16.
17.

Microfibril-associated glycoprotein binds to the carboxyl-terminal domain of tropoelastin and is a substrate for transglutaminase.

Brown-Augsburger P, Broekelmann T, Mecham L, Mercer R, Gibson MA, Cleary EG, Abrams WR, Rosenbloom J, Mecham RP.

J Biol Chem. 1994 Nov 11;269(45):28443-9.

18.

Laminin-1 and laminin-2 G-domain synthetic peptides bind syndecan-1 and are involved in acinar formation of a human submandibular gland cell line.

Hoffman MP, Nomizu M, Roque E, Lee S, Jung DW, Yamada Y, Kleinman HK.

J Biol Chem. 1998 Oct 30;273(44):28633-41. Erratum in: J Biol Chem 1999 Apr 30;274(18):12950.

19.

The N-terminal A domain of Staphylococcus aureus fibronectin-binding protein A binds to tropoelastin.

Keane FM, Clarke AW, Foster TJ, Weiss AS.

Biochemistry. 2007 Jun 19;46(24):7226-32. Epub 2007 May 22.

PMID:
17516661
20.

The critical interaction of the metallopeptidase PHEX with heparan sulfate proteoglycans.

Barros NM, Nascimento FD, Oliveira V, Juliano MA, Juliano L, Loisel T, Nader HB, Boileau G, Tersariol IL, Carmona AK.

Int J Biochem Cell Biol. 2008;40(12):2781-92. doi: 10.1016/j.biocel.2008.05.021. Epub 2008 Jun 8.

PMID:
18585473

Supplemental Content

Support Center